Status:
COMPLETED
Testosterone and Vascular Function in Reproductive-Aged Females With Chronic Kidney Disease
Lead Sponsor:
University of Calgary
Conditions:
Chronic Kidney Diseases
Cardiovascular Diseases
Eligibility:
FEMALE
18-51 years
Brief Summary
Cardiovascular disease (CVD) is the leading cause of death among women and women with chronic kidney disease are at an even greater risk of CVD. The aim of this observational study is to examine the r...
Eligibility Criteria
Inclusion
- female sex
- a diagnosis of chronic kidney disease or end stage kidney disease
- age 18-51
Exclusion
- Pregnancy, breastfeeding, current use of menopausal hormone therapy or gender affirming hormone therapy, or factors that would affect ovarian function, such as polycystic ovarian syndrome, premature ovarian insufficiency, ovarian malignancy, gonadotoxic chemotherapy, surgical oophorectomy, or previous radiation to the pelvis.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT06107166
Start Date
June 1 2018
End Date
December 31 2021
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T2N1N4